New option listings for December 8th include Cboe Magnificent 10 Index (.MGTN), Leverage Shares 2x Long ABNB Daily ETF (ABNG), Leverage Shares 2X Long BLSH Daily ETF (BLSG), Leverage Shares 2X Long BMNR Daily ETF (BMNG), Leverage Shares 2X Long CMG Daily ETF (CMGG), Brp Inc. (DOO), Leverage Shares 2x Long FUTU Daily ETF (FUTG), Leverage Shares 2X Long GEMI Daily ETF (GEMG), Leverage Shares 2X Long NBIS Daily ETF (NBIG), Leverage Shares 2X Long OKTA Daily ETF (OKTG), and SAB Biotherapeutics Inc (SABS). Option delistings effective December 8th include BRP (DOOO) and Unilever (UL).
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SABS:
- SAB Biotherapeutics to present data on progress in development of SAB-142
- SAB Biotherapeutics Reports Positive Q3 2025 Earnings
- Sab Biotherapeutics, Inc. (SABS) Q3 Earnings Cheat Sheet
- Promising Clinical Developments and Strategic Decisions Justify Buy Rating for SAB Biotherapeutics
- Promising Phase 1 Data for SAB-142 Supports Buy Rating for SAB Biotherapeutics